This pooled analysis study examines 1-year outcomes in women and minorities vs white men following percutaneous coronary intervention with everolimus-eluting stents.
This study examines the strength of association between a prior, a current, or a change in Kansas City Cardiomyopathy Questionnaire scores with death and hospitalization in patients with preserved and reduced ejection fractions using.
This study uses the AHRQ NIS data set to examine the association of hospital procedure volume with hospital performance for aortic and mitral valve surgical procedures.
This cohort study compares improvement in prognostication of long-term incident coronary heart disease and atherosclerotic cardiovascular disease using coronary artery calcium scores among individuals with diabetes, metabolic syndrome, or neither condition who participated in the Multi-Ethnic Study of Atherosclerosis.
This cohort study examines differences in the prevalence of and risk for intracranial atherosclerotic disease between black and white men and women.
This prospective study explores the association between higher levels of physical activity and all major subtypes of cardiovascular disease in Chinese men and women.
This study tests the hypothesis that patients with borderline pulmonary hypertension have decreased survival compared with patients with lower mean pulmonary arterial pressure and frequently develop overt pulmonary hypertension.
This study used a Markov decision model to determine the cost-effectiveness of a PCSK9 inhibitor and statin treatment strategy compared with a statin-alone strategy, using results of the FOURIER trial.
This study evaluates the feasibility, process, and outcomes of a reproduction analysis of the SMART-AF trial using shared clinical trial data..
This randomized clinical trial evaluates whether chewing a loading dose of ticagrelor, 180 mg, vs traditional oral administration of an equal dose enhances platelet inhibition at 30 minutes and 1 hour after loading dose administration in patients with ST-segment elevation myocardial infarction.
This secondary analysis of a randomized clinical trial compares outcomes of evolocumab and placebo for subgroups of patients with stable atherosclerotic cardiovascular disease.
This Viewpoint compares the robustness of cancer drug development with the decline of cardiovascular drug development and evaluates how pricing models affect each.
This Viewpoint gives reasons why cardiovascular drug development has stalled in recent years and proposes options for lowering the regulatory, financial, and scientific barriers to cardiovascular drug development.
A 52-year-old man with mild asthma who experienced an episode of unheralded syncope while walking has sinus bradycardia and first-degree atrioventricular, left posterior fascicle, and right bundle branch blocks on electrocardiography. What is your diagnosis?
This article outlines steps to prevent and manage high blood pressure.
Create a personal account or sign in to: